HFCAS OpenIR

浏览/检索结果: 共3条,第1-3条 帮助

限定条件    
已选(0)清除 条数/页:   排序方式:
Niraparib maintenance therapy in patients with platinum-sensitive recurrent ovarian cancer and a time-to-progression after penultimate platinum-based chemotherapy of 6-12 or > 12 months: a subgroup analysis of the phase III NORA trial 期刊论文
GYNECOLOGIC ONCOLOGY, 2021, 卷号: 162
作者:  Huang, Qidan;  Wu, Xiaohua;  Zhu, Jianqing;  Wang, Danqing;  Yang, Jiaxin;  Wang, Jing;  Wu, Lingying;  Liu, Ziling;  Gao, Yunong;  Wang, Danbo;  Lou, Ge;  Yang, Hongying;  Zhou, Qi;  Kong, Beihua;  Huang, Yi;  Chen, Lipai;  Li, Guiling;  An, Ruifang;  Wang, Ke;  Zhang, Yu;  Yan, Xiaojian;  Lu, Xin;  Wang, Li;  Tan, Tao;  Dong, Juan
收藏  |  浏览/下载:61/0  |  提交时间:2021/11/01
Efficacy and safety of niraparib maintenance therapy in patients with platinum-sensitive recurrent ovarian cancer with complete or partial response to the last platinum-based chemotherapy: a subgroup analysis of the phase III NORA trial 期刊论文
GYNECOLOGIC ONCOLOGY, 2021, 卷号: 162
作者:  Yang, Jiaxin;  Wu, Xiaohua;  Zhu, Jianqing;  Song, Liang;  Feng, Yanling;  Wang, Jing;  Wu, Lingying;  Liu, Ziling;  Gao, Yunong;  Wang, Danbo;  Lou, Ge;  Yang, Hongying;  Zhou, Qi;  Kong, Beihua;  Huang, Yi;  Chen, Lipai;  Li, Guiling;  An, Ruifang;  Wang, Ke;  Zhang, Yu;  Yan, Xiaojian;  Lu, Xin;  Wang, Li;  Tan, Tao;  Dong, Juan
收藏  |  浏览/下载:74/0  |  提交时间:2021/11/01
Fuzuloparib maintenance therapy in patients with platinum-sensitive, relapsed ovarian cancer: a multicenter, randomized, double-blind, placebo-controlled, phase III trial 期刊论文
GYNECOLOGIC ONCOLOGY, 2021, 卷号: 162
作者:  Li, Ning;  Zhang, Youzhong;  Wang, Jing;  Zhu, Jianqing;  Wang, Li;  Wu, Xiaohua;  Yao, Desheng;  Wu, Qiang;  Liu, Jihong;  Tang, Junying;  Yin, Rutie;  Zhang, Guonan;  Lou, Ge;  An, Ruifang;  Xia, Xiaoping;  Li, Qingshui;  Zhu, Yaping;  Hong, Zheng;  Yang, Xinfeng;  Hu, Yuanjing;  Zhang, Xin;  Wan, Xiaoyun;  Qu, Jing;  Zhang, Ben;  Wu, Lingying
收藏  |  浏览/下载:64/0  |  提交时间:2021/11/01